MEI Pharma Inc (MEIP)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Daniel P. Gold
Employees:
100
11455 EL CAMINO REAL, SUITE 250, SAN DIEGO, CA, 92130
858-369-7100
-
Formally known as:
- Marshall Edwards Inc.
Date | Ratio |
---|---|
2010-03-31 | 1:1 |
2012-12-19 | 1:6 |
2023-04-17 | 1:20 |
MEI Pharma, Inc. focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trials for patients with relapsed/refractory follicular lymphoma, as well as in Phase Ib multi-arm trial to treat B-cell malignancies. It also develops ME-344, a mitochondrial inhibitor targeting the oxidative phosphorylation complex in Phase I clinical trial for human epidermal growth factor receptor 2 negative breast cancer.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|